WOLVERINE ASSET MANAGEMENT LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,278,000
+400.9%
92,346
+54.0%
0.06%
+460.0%
Q4 2018$854,000
+238.9%
59,984
+261.3%
0.01%
+233.3%
Q3 2018$252,000
-9.4%
16,6000.0%0.00%
-25.0%
Q2 2018$278,000
-49.8%
16,600
-51.2%
0.00%
-42.9%
Q1 2018$554,000
-85.0%
34,000
-88.2%
0.01%
-81.6%
Q4 2017$3,693,000
+30.8%
288,600
+25.7%
0.04%
+22.6%
Q3 2017$2,824,000
+53.6%
229,600
+4.6%
0.03%
+34.8%
Q2 2017$1,838,000
-14.3%
219,600
-8.5%
0.02%
-32.4%
Q1 2017$2,144,000
+11.0%
240,000
+9.1%
0.03%
+36.0%
Q4 2016$1,932,000
+37.6%
219,900
+5.7%
0.02%
+19.0%
Q3 2016$1,404,000
+156.7%
208,100
+35.3%
0.02%
+162.5%
Q2 2016$547,000
+21.8%
153,800
+4193.7%
0.01%
-38.5%
Q1 2016$449,000
+87.1%
3,582
+33.6%
0.01%
+160.0%
Q4 2015$240,000
+133.0%
2,682
+194.7%
0.01%
+150.0%
Q3 2015$103,000
-20.8%
910
-61.2%
0.00%
-33.3%
Q2 2015$130,000
-16.1%
2,346
+19.2%
0.00%
-25.0%
Q1 2015$155,000
+416.7%
1,968
+47.2%
0.00%
+300.0%
Q4 2014$30,000
-88.7%
1,337
-77.6%
0.00%
-83.3%
Q3 2014$266,000
+1377.8%
5,977
+2400.8%
0.01%
Q2 2014$18,000
-92.2%
239
-93.7%
0.00%
-100.0%
Q1 2014$230,000
+198.7%
3,818
+66.8%
0.01%
+150.0%
Q4 2013$77,000
-63.5%
2,289
-66.6%
0.00%
-60.0%
Q3 2013$211,0006,8630.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
BVF INC/IL 9,169,276$66,110,00011.67%
Redmile Group, LLC 13,623,620$98,226,0008.05%
First Light Asset Management, LLC 849,374$6,124,0002.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,529,361$68,707,0002.29%
Opus Point Partners Management, LLC 320,000$2,307,0001.83%
KOPP INVESTMENT ADVISORS LLC 383,022$2,762,0001.23%
Artal Group S.A. 3,710,000$26,749,0001.15%
EcoR1 Capital, LLC 400,000$2,884,0000.96%
Cormorant Asset Management, LP 850,000$6,129,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 800,000$5,768,0000.56%
View complete list of ARRAY BIOPHARMA INC shareholders